Gene therapy meets vaccine development.
Therapeutic vaccines such as those used to combat cancer or persistent viral infection are required to reprogramme a downregulated immune system. This presents a difficult challenge for vaccine design and merits the development of novel immunization protocols. Currently, we know that mobilization of...
Main Authors: | , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|